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ABSTRACT 
 
Objective: Characterize the users of oral anticoagulant therapy; to find out about treatment regimen 
management and to estimate International Normalized Ratio (INR) assessment costs.  
 
Methodology: Descriptive, exploratory, cross-sectional study with 83 users of oral anticoagulant 
therapy from a primary health care centre in Alentejo (Portugal). Data collection occurred with the 
application of a questionnaire designed for the purpose.  
 
Results: It was found that 50.6% reported that they did not know what clotting is; 49.4%, what oral 
anticoagulants are; 63.9%, what the complications are of oral anticoagulant therapy. Only 27.7% know 
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the foods that interfere with this therapy, and 51.8% mentioned that they knew what to do in the event of 
injury, tooth extraction or surgery. INR assessment costs in the laboratory are higher than in the primary 
health care centre.  
 
Conclusions: Gaps in knowledge regarding coagulation, food interference and treatment regimen were 
identified. The decentralisation of nursing appointments enables costs to be reduced, improves 
accessibility and management of the treatment regimen. 
 
RESUMO 
 
Objetivo: Caraterizar os utentes com terapia anticoagulante oral; conhecer a gestão do regime 
terapêutico e estimar custos da avaliação de Razão Normatizada Internacional (RNI).  
 
Metodologia: Estudo descritivo, exploratório, transversal, realizado com 83 utentes com terapia 
anticoagulante oral de um Centro de Saúde do Alentejo (Portugal). A coleta dos dados ocorreu com 
aplicação de questionário construído para o efeito.  
 
Resultados: Concluiu-se que 50,6% referiram não saber o que é coagulação; 49,4% o que são 
anticoagulantes orais; 63,9% quais as complicações da terapêutica anticoagulante oral. Apenas 27,7% 
conhecem os alimentos que interferem com esta terapêutica e 51,8% mencionam saber o que fazer em 
caso de ferida, extração de dente ou cirurgia. O custo da avaliação de RNI em laboratório é mais 
elevado que nos Centros de Saúde.  
 
Conclusões: Identificaram-se lacunas nos conhecimentos sobre coagulação, interferências 
alimentares e regime terapêutico. A descentralização da Consulta de Enfermagem permite reduzir 
custos, melhorar a acessibilidade e gestão do regime terapéutico 
 
RESUMEN 
 
Objetivo: Caracterizar a los usuarios con terapia anticoagulante oral; conocer el régimen de 
tratamiento y estimar los costes de evaluación de la International Normalized Ratio (INR).  
 
Metodologia: Estudio descriptivo, transversal exploratorio, con 83 usuarios con terapia anticoagulante 
oral de un Centro de Salud de Alentejo. Los datos fueron recolectados con la aplicación de cuestionario 
construido para este fin.  
 
Resultados: Se concluyó que 50,6% informaron no saber qué es la coagulación; 49,4% lo que son 
anticoagulantes orales; 63,9% las complicaciones de la terapia anticoagulante oral. 27,7% conoce los 
alimentos que interfieren con esta terapia y 51,8% declara saber qué hacer en caso de lesión, cirugía o 
de la extracción de un diente. El costo de la evaluación de IRN  en laboratorio es mayor que en los 
centros de salud.  
 
Conclusiones: Existen lagunas en el conocimiento sobre el proceso de coagulación, la interferencia de 
alimentación y el régimen. La descentralización de la consulta de enfermería puede reducir los costos, 
mejorar la accesibilidad y la gestión del régimen terapéutico. 
 
INTRODUCTION 
 
Cardiovascular diseases are a group of diseases that affect the cardiovascular 
system, specifically the heart and blood vessels. Their consequences are often 
sudden and unexpected, sometimes culminating in the death of the person. The 
control of risk factors and effective management of the therapy regimen may 
contribute to a reduction in fatal and non-fatal complications of cardiovascular 
diseases (1).
 
 
With an ageing population and its impact in terms of health and current eating habits, 
the situation is likely to worsen. According to the United Nations (UN), the world's 
elderly population is growing 2% each year and the proportion of elderly is growing 
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faster than any other age group. Around the year 2050, the elderly will represent one 
1/5 of the elderly(2). Investments must be made in education in order to prevent these 
diseases and their consequences.  
 
 “The high domestic prevalence of risk factors for cardiovascular diseases 
requires particular attention to be paid to effective prevention, detection and 
correction, taking into account that the concept behind this term incorporates 
not only action that prevents a loss of health, but also all care that promotes 
recovery. It also requires the adoption of integrated and complementary 
measures that foster, among the Portuguese population, a reduction in the risks 
of contracting these diseases, prompt and appropriate treatment and secondary 
prevention measures that reduce their recurrence”(3).  
 
Some examples of situations where oral anticoagulant therapy (OAT) is recommended 
are: the prevention of deep vein thrombosis and pulmonary embolisms; the prevention 
of clots and emboli in patients with artificial heart valves; preventing the formation of 
clots and emboli in patients with atrial fibrillation and prevention of myocardial 
infarction in some patients with specific characteristics. It may also be considered for 
patients who are to undergo complicated surgery or those that require prolonged 
immobilisation (4).
        
 
Oral anticoagulants are used within the framework of primary and secondary 
prevention of thromboembolic events, so there are a large number of patients using 
this type of medication prescribed for long periods of time. Effective management of 
the treatment regimen is important as, where a disease situation is concerned, there is 
often a need to change lifestyles, which is not always accepted by patients, resulting in 
risks to health and the prevention of complications; at the same time, determining the 
appropriate therapeutic dose of these drugs is also complex.  
 
According to the Ministry of Health, around 40% of deaths recorded in Portugal are 
due to cardiovascular disease, and half of these deaths are the result of cerebral 
vascular problems. Pathological conditions such as atrial fibrillation (AF) lead to a high 
number of patients having to undergo daily anticoagulant therapy to prevent 
thromboembolic events such as stroke. It is estimated that there are approximately 
100 thousand patients taking anticoagulants in Portugal, this number increasing 
significantly every year (1).
  
 
The haemostatic system comprises an entire vascular endothelium and platelets and 
coagulation factors in the bloodstream. Its main function is to maintain the fluidity of 
the blood and stop bleeding when a vascular injury occurs. Complete balance is 
required between the coagulation, or fibrin formation, mechanisms and the fibrinolytic, 
or fibrin destruction, mechanisms. Oral anticoagulants derived from 4-
hydroxycoumarin (acenocoumarol and warfarin sodium) are indirect action 
anticoagulants that reduce the hepatic synthesis of factors II, VII, IX and X of the 
coagulation, by antagonising the action of vitamin k (phytomenadione). Unlike heparin, 
they have no anticoagulant effect in vitro. The most representative drug is warfarin; 
acenocoumarol is used less frequently. They prolong prothrombin time (PT), which 
assesses the integrity of the extrinsic system and is used to control the anticoagulant 
effect; it is referred to as the INR (International Normalised Ratio); they also increase 
the activated partial thromboplastin time (APTT), which measures the integrity the 
intrinsic system. Coumarin-type oral anticoagulants (e.g., warfarin and 
acenocoumarol) act by blocking, at the hepatocyte level, the carboxylation of vitamin 
K-dependent proteins, and are increasingly used in primary and secondary prophylaxis 
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of thromboembolic disease(4).Despite better definition of the therapeutic areas and 
greater standardisation of laboratory monitoring, these drugs are not free from 
haemorrhagic and thromboembolic complications, often consequences of an 
excessive anticoagulant effect and insufficient anticoagulation, respectively. Thus, it 
becomes essential to monitor them by means of laboratory tests to ascertain 
prothrombin time (expressed in INR)(5.7).
  
 
The literature reveals that the majority of OAT patients are female, with an average 
age close to 60 years of age, married, retired, with associated diseases, which have 
been undergoing this therapy for more than 5 years, with INR valueswithin the 
therapeutic parameters (6-7).
 The use of OAT requires care in order to maintain levels of 
blood coagulation under control and prevent thromboembolic or haemorrhagic 
complications. Sometimes such care can lead to changes in lifestyle, changes in 
dietary habits, alcohol consumption, daily intake of medication, observation 
consultations and fear of complications, which may compromise the quality of life of 
these people(7).
  
 
Users of oral anticoagulant therapy need to be monitored once or twice a month to 
control the therapeutic dose, taking into account the levels of anticoagulation and the 
dangers of overdose. According to the figures agreed by the guidelines of the seventh 
conference of the American College of Chest Physicians, the target INR value should 
be equal to 2.5 ± 0.5 and a nursing consultation at the primary health care centre has 
the advantage for the patient of offering more frequent tests, with less risk of bleeding 
and its effects, increased independence and with results as reliable as the laboratory 
method, with dosing being changed immediately after determination of the INR(8).
 
Accordingly, the existing human and physical resources should be managed and 
focused on allowing access to the widest number of users who are dependent on 
them, in order to reduce the mortality and morbidity of these diseases(9). The policy of 
decentralisation aims to delegate roles and/or decision-making, charging other 
professionals with performing the same tasks at another location. Decentralising the 
Anticoagulation Consultation and the monitoring of INR in hospitals or clinical analysis 
laboratories to primary health care centres enables patients to get closer to the health 
care they need, ensuring greater accessibility and proximity, at a lower cost. 
 
This study aims to: Identify and characterise users of oral anticoagulant therapy; 
analyse treatment regimen management and estimate INR (International Normalized 
Ratio) assessment costs. 
METHODOLOGY  
 
A descriptive, exploratory, cross-sectional study taking a quantitative approach. The 
study population consists of the total number of users of oral anticoagulant therapy 
registered at a primary health care centre in Alentejo (Portugal), a total of 83, whose 
selection criteria consisted of being over 18 years of age and undergoing monitoring of 
INR and respective control of the therapeutic dose at that primary health care centre, 
after informed consent. For data collection, a questionnaire was applied, which had 
been previously tested on a sample population with characteristics similar to those of 
the study population. The questionnaire was developed based on the literature 
consulted in order to meet the objectives and, despite the various possible 
components of the management of the treatment regimen, only the cognitive 
component was considered. 
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The first part intends to provide a socio-demographic description of the users, and the 
second asks some questions in order to evaluate the patients’ perception and 
knowledge regarding coagulation, what oral anticoagulants are, the complications of 
this type of therapy, the information they have about the correct way to take the 
medicine, what to do in the event of forgetting a dose, the importance of attending for 
INR assessment on the established dates, considering whether the anticoagulant 
patient can/should live a normal life, which medicines may be taken, foods that 
interfere with oral anticoagulant therapy and care in the event of injury, the need to 
extract a tooth or undergo surgery.  
 
The questionnaire was given to the patients when they attended the primary health 
care centre for INR monitoring and control of the respective therapeutic dose. 
 
In order to meet the latter objective, i.e. to estimate the costs of INR assessment, the 
respective calculations were prepared for evaluation in a clinical laboratory at the 
primary health care centre and main advisory services. The cost of the INR analysis 
tabulated by Ordinance no. 839-A/2009 of 31 July was used as a reference.  
 
In assessing the costs, essentially user-centred parameters were considered, except 
for the cost of the analysis, which did not take into account the costs involved in 
technicians' work.  
 
All ethical procedures were followed (informed consent, confidentiality and anonymity) 
in accordance with the Declaration of Helsinki on Ethics in Research Involving 
Humans.  
Descriptive statistical processing of the data then followed, using relative and absolute 
frequencies, by means of the Statistical Package for the Social Sciences (SPSS®)18.0.  
 
RESULTS 
 
After analysing the data, we could conclude that most of the users of oral 
anticoagulant therapy that responded are female (56.6%) and 71 to 80 is the age 
group with the largest number of patients (43.4%), most are married (67.5%), 
immediately followed by widows (24.1%). Most have already retired (86%). With 
regard to knowledge about what coagulation is, 50.6% stated that they have no 
knowledge regarding this subject. However, despite the previous response when 
several hypotheses have been submitted to choose, 50.6% of respondents recognized 
that coagulation is a natural process that enables the body to reduce blood loss in 
case of bleeding. In relation to users’ knowledge regarding what oral anticoagulants 
are, around 50.6% answered affirmatively, considering them to be medicines that 
cause the blood to take longer to coagulate. It may also be concluded that most users 
of oral anticoagulant therapy (63.9%) do not know the complications associated with 
OAT. Patients who claim to know what the complications of oral anticoagulant therapy 
are mentioned the main complication as being bleeding. The data show that 63.9% 
know what to do if they forget a dose of the oral anticoagulant, but around a quarter of 
this group does not adopt the correct procedure if they forget one. It was also 
observed that 60.2% know what drugs may be taken while undergoing OAT. The 
results indicate that the majority of users surveyed (72.3%) reported not knowing 
which foods interfere with OAT. In relation to precautions to be taken in the event of 
injury, the need for tooth extraction or surgery, 51.8% responded correctly.  
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It resulted from the analysis of the data that 94% of those surveyed believe that an 
user of oral anticoagulant therapy can and should live a normal life, reinforcing the 
importance of attending INR evaluations on the established dates, and the 6% who 
made reference to the limitations that compromise their normal life accentuate 
increased care in relation to the risk of falls, wounds and cuts that may trigger 
bleeding.  
 
The majority of patients (85.5%) report having information that they should only 
undergo the therapy prescribed by the doctor, and only after informing that, they are 
undergoing OAT.  
 
Another objective of the study was to estimate the costs of INR assessments. The 
importance of this objective lies in the fact that this patients need to monitor their INR 
values once or twice a month in order to control the prescribed therapeutic dose, 
bearing in mind the levels of anticoagulation and the risk of overdose. Accordingly, a 
plan was drafted for their evaluation in a clinical laboratory at the health care centre 
and main advisory services, thus avoiding patient visits, which ended up reducing 
costs considerably. Taking the INR cost analysis tabulated by Ordinance no. 839-
A/2009 of 31 July(10) as a reference (4.70 €), a simulation was carried out of the costs 
at the various sites where it is possible for the study population to evaluate INR, as per 
Table I.  
 
     Table I – INR Assessment costs      
Evaluation costs INR / wearer 
Laboratory for clinical analysis 
Evaluation costs INR / patient at the 
Primary Health Care Centre 
Evaluation costs INR / user in the 
local unit of the Primary Health Care 
Centre (no need to travel) 
  Prescription charges - € 3 
  Bus ticket to nearest town 
(roundtrip) - 2.30 € 
  Cost analysis - € 4.70 
  
Total Cost: 10.00€ 
  
  Prescription charges -  0€ 
  Bus ticket to nearest town 
(roundtrip) - 2.30 € 
  Estimated cost analysis 
(including lancet and test strip) - 
€ 1.21 
Total Cost: 3.51€ 
  
  Prescription charges -  0€ 
  Bus ticket – 0€ 
  Estimated cost analysis 
(including lancet and test strip) – 
1,21€  
  Total Cost: 1.21€ 
  
 
   We can thus conclude that INR assessment in a clinical laboratory is, undoubtedly, 
the most expensive, followed by evaluation at the health care centre, taking into 
account that the patient will have to travel from one parish to the county town, it thus 
being more economical to decentralise the nursing consultation and the INR 
assessment for patients undergoing oral anticoagulant therapy to the health advisory 
services. The decentralisation of nursing appointments for those patients thus enables 
costs to be reduced, improves accessibility and promotes more effective management 
of the treatment regimen. 
 
DISCUSSION  
 
Most patients know that coagulation is a natural process that enables the body to 
reduce blood loss in the event of bleeding and that OAT makes the blood take longer 
to coagulate. Most say that they do not know the complications of OAT, but report the 
bleeding as the main complication. Studies indicate that bleeding is the most common 
adverse event(11,12). Fear of bleeding may sometimes lead to high anxiety levels, 
especially in people who have already been through this situation(7).  
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They also mention being informed by their doctor about the proper way to take the 
OAT and how to proceed in the event of forgetting a dose. Almost all of the 
respondents consider it important to meet the INR assessment dates, and see no 
reason not to carry on a normal life, whereby, when there is reference to the reasons 
that prevent a normal day-to-day life, they point to increased precautions in relation to 
the risk of falls and cuts that may trigger bleeding. Studies indicate that the quality of 
life assessment showed the worst among elderly women who have been undergoing 
the therapy for less than one year. The highest quality of life is related to social 
aspects and the worst inherent to the physical aspects(7).  
 
With respect to the foods that interfere with OAT, many doubts and a lack of 
knowledge were identified. The dose of anticoagulant should be adjusted in 
accordance with a healthy diet, and never the opposite. The way in which the INR 
value responds to the consumption of various types of vegetables also varies from 
individual to individual, and so it is critical to maintain regular control of the INR(11,13,17). 
It may also be concluded that, in relation to the precautions to be taken in the event of 
injury, the need to extract a tooth or undergo surgery, the patients state that they know 
what attitudes to adopt, except in the case of the need to extract a tooth. These 
recommendations are crucial and health professionals must be made aware of these 
issues(11). However, one study indicates that although the majority of doctors (60%) 
questioned patients about using OAT during consultations, they demonstrate 
insufficient knowledge about this subject, and 92% are interested in knowing more 
about OAT(12).  
 
The study also enabled us to conclude that INR assessment in a clinical laboratory is, 
undoubtedly, the most expensive (10.00€), followed by evaluation at the health care 
Centre, taking into account that the patient will have to travel from one parish to the 
county town (3.51€), it thus being more economical to decentralise the Nursing 
Consultation for patients undergoing OAT to the health advisory services (1.21€). A 
cost-effectiveness and cost-utility study carried out in Portugal has enabled a 
comparative analysis to be undertaken of costs, years of life and quality of life, 
considering that INR valuescould be self-monitored, monitoring at a primary health 
care centre and monitored at a clinical laboratory. It was found that self-monitoring is 
an alternative that is more beneficial in terms of gain in years and quality of life and 
alternative monitoring in a clinical laboratory is one that offers less benefits, both in 
terms of gains in years of life and quality of life. In relation to direct costs, monitoring at 
primary health care centres offers the lowest costs, as opposed to monitoring in a 
laboratory, which involves the highest costs. The researchers concluded that both self-
monitoring and monitoring at a primary health care centre are dominant in relation to 
monitoring at a clinical laboratory, both involving lower direct and indirect costs and 
greater gains in terms of years of life and quality of life(8). 
 
This decentralisation facilitates access to, not only quality, but also timely health care, 
taking a holistic view of the patient at the most appropriate location for the target 
population. The National Health Plan 2012-2016 states that the “adequate access is 
one of the determinants of health, as it enhances the reduction of inequalities”(15). 
 
CONCLUSIONS 
 
Health is a fundamental human right and an indispensable factor for the economic and 
social development of any region. Health Promotion is an essential process of 
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empowering patients to control and improve their health. Acting on the determinants of 
health not only contributes to health gains, but also reduces inequalities and hence the 
promotion of fundamental rights of the human being. Health should be understood as 
a resource for life, i.e. the user must be proactive, learning skills to take maximum 
responsibility and autonomy, modifying behaviours and thereby promoting self-care. 
 
We may conclude by analysing the data that there are some gaps in relation to 
knowledge that user of oral anticoagulant therapy possess in relation to the 
management of the treatment regimen, including knowledge of the coagulation 
process, food and drug interference and execution of the OAT. The guidelines of the 
National Health Plan 2011-2016 defend a health system whose conceptual model 
seeks to maximise health gains through sustained effort from all sectors, with 
emphasis on equity and access to quality health policies geared towards reducing 
inequalities.  
 
Thus, it is suggested that, in order to empower these patients, education sessions on 
health, both individual and in groups, on food, drug interactions and management of 
the therapeutic regimen should be scheduled. Decisions related to health cease to be 
almost exclusively centred on professionals and move towards the patient who is the 
subject of the care. This paradigm shift demonstrates that reflection on the value of 
personal autonomy has led health professionals to rethink the role of patients, leading 
to them being gradually integrated into decision-making and health care planning(14). 
 
In fact, “the changes in the demographic profile, the indicators of morbidity and the 
emergence of chronic diseases translate into new health needs, the role of primary 
health care having been recognised in recent years, with emphasis on responsiveness 
in solving the problems posed by citizens in order to form a strong and dynamic 
society”(16). 
 
It seems interesting to us to, in the future, established interventions for this population, 
in order to bridge the gaps found in terms of knowledge and evaluate their health-
related quality of life, for which a tool such as the Medical Outcomes Survey 36 – Item 
Short-Form (SF-36), in the validated Portuguese version, may be used(7) .  
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